Standout Papers
- K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer (2008)
- Expression of Epiregulin and Amphiregulin and K-ras Mutation Status Predict Disease Control in Metastatic Colorectal Cancer Patients Treated With Cetuximab (2007)
- Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab (2010)
Immediate Impact
2 by Nobel laureates 16 from Science/Nature 160 standout
Citing Papers
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C
2023 Standout
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Works of Shirin Khambata‐Ford being referenced
K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
2008 Standout
Multicenter Phase II and Translational Study of Cetuximab in Metastatic Colorectal Carcinoma Refractory to Irinotecan, Oxaliplatin, and Fluoropyrimidines
2006
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Shirin Khambata‐Ford | 4391 | 2191 | 1521 | 34 | 5.4k | |
| Christiane Langer | 4496 | 1956 | 1493 | 26 | 5.7k | |
| Angela Zubel | 4746 | 1921 | 1346 | 33 | 5.6k | |
| Sabine Tejpar | 4017 | 1903 | 1616 | 77 | 5.2k | |
| Michael Schlichting | 5076 | 1988 | 1551 | 43 | 6.0k | |
| Piercarlo Saletti | 4167 | 2040 | 1565 | 74 | 5.4k | |
| Delphine Le Corre | 2935 | 1327 | 1285 | 33 | 4.6k | |
| Rafael G. Amado | 4917 | 2258 | 1487 | 56 | 6.5k | |
| Kelly S. Oliner | 4523 | 2561 | 1591 | 67 | 6.3k | |
| Christopher R. Garrett | 2754 | 2358 | 758 | 49 | 5.2k | |
| Gorana Tomasic | 4340 | 1383 | 1311 | 63 | 5.9k |
All Works
Loading papers...